SENS-AI
SOL Trading Statement Neutral

SASOL LIMITED - Trading Statement for the Year Ended 30 June 2026

Sasol Limited
Full analysis

What this filing means

Sasol guides FY2026 adjusted EBITDA 12%–20% higher to R58–R62bn and HEPS 2%–14% up to R36–R40, with EPS soaring 65%–84% off a depressed base. Operating drivers look genuine — sales volumes up 4%, Brent crude +7%, refining margins more than doubled. But the share ran up 8.9% in the 20 days before the print, so the operating step-up is largely in the price. The flashy EPS recovery is mostly smaller impairments (R16.8bn vs R20.7bn), not core earnings acceleration.

For a normal person: Sasol made more money this year than last — that's the headline. But the big EPS jump is mostly because last year had huge write-downs, not because the underlying business dramatically improved. The real story is adjusted EBITDA up 12-20%, which is solid. The catch: the share price already rose 8.9% in the weeks before this announcement, so much of this good news was already reflected. It's confirmation of an improving year, not a fresh reason to chase the stock higher.

Bull case

  • Adjusted EBITDA is guided up 12-20% to R58-R62bn from R51.8bn, marking a clear operating earnings step-up.
  • HEPS is guided at R36-R40 versus prior-year R35.13, a 2-14% increase confirming positive underlying earnings momentum.
  • EPS guided at R17.50-R19.50, up 65-84% from a depressed R10.60 base, signalling reported earnings recovery.

Bear case

  • HEPS growth of just 2-14% reveals the operating earnings engine barely accelerated, with the flashy 65-84% EPS recovery driven mostly by shrinking impairments rather than core performance.
  • The Secunda liquid fuels refinery CGU remains fully impaired despite management actions, signalling persistent structural challenges in the group's core fuels business.
  • Stronger Rand assumptions already triggered a R3.7bn Polyethylene CGU impairment, and with Sasol unhedged, any further Rand appreciation directly erodes dollar-denominated chemical earnings.
  • Working capital drag from Middle East-linked pricing and a fuels inventory build is expected to moderate free cash flow improvement, so the headline earnings recovery may not translate into cash.
  • Heps vs eps: EPS midpoint +74.5% (R17.50-R19.50) vs HEPS midpoint +8% (R36-R40). Filing explicitly states lower impairments (R16.8bn vs R20.7bn) drive EPS; HEPS strips these out. HEPS is the like-for-like operating measure and shows minimal growth.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

A real operating beat — adjusted EBITDA up 12-20%, sales volumes +4%, refining margins more than doubled — but the share ran up 8.9% into the print, so the news is largely priced in. The flashy 65-84% EPS jump is mostly smaller impairments, not core earnings power: HEPS only rises 2-14%. Secunda remains fully impaired, the stronger Rand already triggered a R3.7bn polyethylene write-down, and working-capital drag will moderate free cash flow. So what: the operating step-up is real but already in the price; the 1 September audited results need to confirm cash conversion and balance-sheet improvement to extend the narrative. Missing evidence: No cash-flow or net debt figures — full results required; No segmental revenue or profit breakdown disclosed; No dividend guidance provided; Unaudited figures — external audit pending; No forward production or cost guidance for FY27

The 1 September audited results are where the market will test whether operating cash backs the earnings beat.

Evidence from the filing

  • Adjusted EBITDA is guided up 12-20% to R58-R62bn from R51.8bn, marking a clear operating earnings step-up.

    “Adjusted earnings before interest, tax, depreciation and amortisation (adjusted EBITDA*) is expected to be between R58 billion and R62 billion (prior year adjusted EBITDA of R51,8 billion), an increase of between 12% and 20% compared to the prior year”

  • HEPS is guided at R36-R40 versus prior-year R35.13, a 2-14% increase confirming positive underlying earnings momentum.

    “Headline earnings per share (HEPS) is expected to be between R36 and R40 per share (prior year HEPS of R35,13), an increase of between 2% and 14% compared to the prior year”

  • EPS guided at R17.50-R19.50, up 65-84% from a depressed R10.60 base, signalling reported earnings recovery.

    “Earnings per share (EPS) is expected to be between R17,50 and R19,50 (prior year EPS of R10,60), representing an increase of between 65% and 84% compared to the prior year”

  • The Secunda liquid fuels refinery CGU remains fully impaired despite management actions, signalling persistent structural challenges in the group's core fuels business.

    “The Secunda liquid fuels refinery cash generating unit (CGU) remains fully impaired”

  • Stronger Rand assumptions already triggered a R3.7bn Polyethylene CGU impairment, and with Sasol unhedged, any further Rand appreciation directly erodes dollar-denominated chemical earnings.

    “Impairment of the Polyethylene CGU of R3,7 billion primarily due to a stronger forecast Rand/US$ exchange rate and lower longer-term US$ price assumptions”

  • Working capital drag from Middle East-linked pricing and a fuels inventory build is expected to moderate free cash flow improvement, so the headline earnings recovery may not translate into cash.

    “higher year-end working capital driven by elevated pricing following the Middle East conflict and the previously reported fuels inventory build, is expected to moderate the improvement in free cash flow generation”

  • The trading statement is unaudited and discloses no segment-level cash flow, capex outcome, or net debt position, leaving cash conversion and balance sheet implications unverified ahead of the 1 September results.

    “The financial information underpinning this trading statement has not been audited and reported on by the Company's external auditors”
Category
Trading Statement
Event posture
Too Late
Published
Aug 5, 2026

More on Sasol Limited

Sasol Limited (SOL) share price All Sasol Limited SENS announcements

Related filings